Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers. β
Go to Publication β
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 59 Issue 10 Pages: 1942-53 Pub: 2015 Oct Epub: 2015 Aug 26 Authors Mosele JI , Gosalbes MJ , Macià A , Rubió L , Vázquez-Castellanos JF , Jiménez Hernández N , Moya A , Latorre A , Motilva MJ , |
|
|
Pomegranate ellagitannins stimulate growth of gut bacteria inΒ vitro: Implications for prebiotic and metabolic effects. β
Go to Publication β
Anaerobe (Anaerobe ) Vol: 34 Issue Pages: 164-8 Pub: 2015 Aug Epub: 2015 Jun 4 Authors Li Z , Summanen PH , Komoriya T , Henning SM , Lee RP , Carlson E , Heber D , Finegold SM , |
|
|
Pomegranate ellagitannins stimulate growth of gut bacteria inΒ vitro: Implications for prebiotic and metabolic effects. β
Go to Publication β
Anaerobe (Anaerobe ) Vol: 34 Issue Pages: 164-8 Pub: 2015 Aug Epub: 2015 Jun 4 Authors Li Z , Summanen PH , Komoriya T , Henning SM , Lee RP , Carlson E , Heber D , Finegold SM , |
|
|
The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial. β
Go to Publication β
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: Issue Pages: e1800160 Pub: 2018 Apr 17 Epub: 2018 Apr 17 Authors González-Sarrías A , Romo-Vaquero M , García-Villalba R , Cortés-Martín A , Selma MV , Espín JC , |
|
|
The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial. β
Go to Publication β
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: Issue Pages: e1800160 Pub: 2018 Apr 17 Epub: 2018 Apr 17 Authors González-Sarrías A , Romo-Vaquero M , García-Villalba R , Cortés-Martín A , Selma MV , Espín JC , |
|
|
The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial. β
Go to Publication β
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: Issue Pages: e1800160 Pub: 2018 Apr 17 Epub: 2018 Apr 17 Authors González-Sarrías A , Romo-Vaquero M , García-Villalba R , Cortés-Martín A , Selma MV , Espín JC , |
|
|
Punicic acid ameliorates obesity and liver steatosis by regulating gut microbiota composition in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2021 Jul 9 Epub: 2021 Jul 9 Authors Yuan G , Tan M , Chen X , |
|
|
Punicic acid ameliorates obesity and liver steatosis by regulating gut microbiota composition in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2021 Jul 9 Epub: 2021 Jul 9 Authors Yuan G , Tan M , Chen X , |
|
|
Dietary pomegranate extract and inulin affect gut microbiome differentially in mice fed an obesogenic diet. β
Go to Publication β
Anaerobe (Anaerobe ) Vol: 48 Issue Pages: 184-193 Pub: 2017 Dec Epub: 2017 Sep 14 Authors Zhang S , Yang J , Henning SM , Lee R , Hsu M , Grojean E , Pisegna R , Ly A , Heber D , Li Z , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
